Toggle light / dark theme

New strategy to fight chronic kidney inflammation

Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells – also known as “zombie cells” – in diabetic kidney disease.

In eBioMedicine, a publication of The Lancet, the team reported that the combination of the cancer drug dasatanib and a naturally occurring substance known as quercetin decreased inflammation and boosted protective factors in the kidney.

Diabetic kidney disease affects more than 12 million people in the U.S. and is the leading cause of kidney failure. While newer treatments can delay loss of kidney function, there is currently no cure.

Alzheimer’s Disease: From Molecular Mechanisms to Promising Therapeutic Strategies

Brain vasculature in ischemic stroke.

Ischemic stroke induces dynamic cellular structural changes in the neurovascular unit, leading to disrupted structural integrity of the blood–brain barrier, neuronal degeneration, and responsive angiogenesis coordinated by endothelial cells, reactive astrocytes, and pericytes.

After ischemic stroke, the neurovascular coupling function of the neurovascular unit is also disrupted, manifested by the metabolic dysregulation of glucose, lipid/fatty acid, and amino acids.

Neurovascular unit dynamic structural remodeling and metabolic dysfunction following ischemic stroke show cellular states and spatiotemporal heterogeneities, revealing new perspectives on ischemic stroke pathogenesis and future therapeutic strategies.

Multidimensional approach aiming to repair neurovascular unit structural disorganization and restore metabolic homeostasis with cellular and spatiotemporal precision is the optimal therapeutic strategy for ischemic stroke. sciencenewshighlights ScienceMission https://sciencemission.com/neurovascular-unit-in-ischemia


The neurovascular unit (NVU) is a multicellular system functioning to maintain healthy brain homeostasis and regulate the exchange of essential elements between the blood and the brain. Recent studies have shown that, in response to ischemic stroke (IS), the NVU undergoes dynamic structural remodeling and metabolic dysfunction, revealing new features of IS pathogenesis. Recent breakthroughs in single-cell multiomics provide emerging evidence regarding the spatiotemporal heterogeneity of NVU responses to IS. To date, clinical treatments for IS-induced brain injury remain very limited. These new studies have advanced our knowledge of the dynamic cellular and molecular changes of the NVU after IS, paving the way for new therapeutic strategies.

Closing in on a universal vaccine: Nasal spray protects mice from respiratory viruses, bacteria and allergens

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy Grail—and about as elusive as a mythological vessel. But Stanford Medicine researchers and collaborators have taken an astonishing step forward in that quest, surprising even themselves.

In a new study in mice, they have developed a universal vaccine formula that protects against a wide range of respiratory viruses, bacteria and even allergens. The vaccine is delivered intranasally—such as through a nasal spray—and provides broad protection in the lungs for several months.

In the study, published in Science, researchers show that vaccinated mice were protected against SARS-CoV-2 and other coronaviruses, Staphylococcus aureus and Acinetobacter baumannii (common hospital-acquired infections), and house dust mites (a common allergen).

The macroecology of immunity: predominant influence of climate on invertebrate immune response

https://vist.ly/4u8bp Macroecology Odonates Parasites

The immune system is the primary defense against parasites. With the ever-increasing rate of disease, epidemiologic models considering geographic variation in immune responses could prove useful. Despite increasing interest in the macroecology of parasitism and infectious diseases, we know little about the macroecology of immune responses (i.e. macroimmunology). Host characteristics, parasite exposure, and environmental factors can all affect immunity, but how these factors shape spatial variation in the strength of immune responses remains underexplored. We captured odonates (dragonflies and damselflies) and their conspicuous ectoparasitic mites from 42 sites spread across a geographic area spanning the temperate and boreal forest biomes in eastern Canada. We then conducted immune response bioassays on 1237 individuals from 63 odonate species. We used generalized additive models and structural equation models to relate immune responses to host body size, parasite load, pH, temperature and precipitation while accounting for spatial autocorrelation in immune ability and evolutionary relationships among host species. We found significant differences in the strength of immune response among host individuals, and this variation was best explained by climatic conditions, specifically strongly decreasing with precipitation. While host species significantly differed in immune response strength, we found no effect of host body size, evolutionary relationships among hosts, or parasitism on immune response. Our study investigating the drivers of immune response across dozens of species spread across two biomes is the most comprehensive to date. Climatic conditions have a strong influence on host immune response, regardless of host characteristics or parasitism rates. Strong immune responses were associated with low levels of annual precipitation, which could relate to the role of cuticular melanin content in desiccation resistance, and the melanin-based encapsulation response being a byproduct of this adaptation. A spatially explicit understanding of the biological processes affecting immunity could improve epidemiological models of disease risk that inform disease management globally.


Predicting parasite and pathogen spread is increasingly relevant and challenging in a highly connected world (Tsiotas and Tselios 2022), and an animal’s immune system is the first line of defense against attack by parasites and pathogens. Yet, the factors driving variation in immunity among individuals, populations, and species are poorly studied and rarely factored into epidemiologic models (Becker et al. 2019). Characteristics of the host, exposure to parasites or pathogens, and the abiotic environment can interact in complex ways to affect immunity (Sweeny and Albery 2022), but their interactions are challenging to elucidate (Johnson et al. 2019).

As the immune system is the primary line of defense against infection by parasites, pathogens, and disease, it is assumed to be costly in terms of fitness and should therefore lead to tradeoffs with life-history traits (e.g. fecundity, fertility, Albery et al. 2021). Although a plethora of studies have provided key evidence of immune variation due to such tradeoffs, most studies emphasize the role of biotic factors such as predation (Duong and McCauley 2016) and resource availability (Hasik et al. 2025a) without considering that of abiotic factors (Lazzaro and Little 2008). A relationship between immune response and temperature is expected in both invertebrate ectotherms (Mastore et al. 2019) and vertebrate endotherms (Butler et al. 2013), due to the thermal sensitivity of the enzymes involved in immune responses (Catalán et al. 2012). When one scales this temperature-dependent immunity to explore the effect of climate (specifically, temperature and humidity), then climate is expected to be a clear driver of geographic variation in immunity (Li et al. 2024).

Parasites are a leading cause of disease and death around the world and thus are drivers of life-history evolution via their effects on host fitness (Hasik and Siepielski 2022a) that have the potential to affect host macroevolutionary dynamics (Hasik et al. 2025b). The majority of organisms on earth are infected by at least one parasite (Price 1980), and yet, we have a very limited understanding of the multifarious factors governing the intensity of infection and, therefore, the health cost. Immune responses are necessary to defend organisms from the deleterious and fitness-reducing effects of parasites (and disease in general, Hasik and Siepielski 2022a). Although there is increasing interest in the macroecology of parasites and infectious diseases (Stephens et al. 2016), we know very little about macroimmunology (Becker et al. 2020). Both among-individual and interspecific variation in immune response surely plays a central role, but the factors regulating immunity in natural settings are poorly understood, which can interfere with the accuracy of predictive epidemiologic models. Environmental factors and local parasite pressure can independently drive differences in immunity across space, but they could also act in concert (Becker et al. 2020). Parasitism varies among host populations distributed across large-scale environmental gradients (LoScerbo et al. 2020, Hasik and Siepielski 2022b) and at fine spatial scales, within populations (Albery et al. 2019, Hasik et al. 2025a). To date, however, the focus on a limited set of taxa, specifically vertebrates (Becker et al. 2020), limits our ability to identify generalities regarding the relative influence of environmental conditions and parasitism on immune defenses that would apply across host–parasite systems (Rolff and Siva-Jothy 2003).

PSA and PSMA kinetics after PSMA-PET & MR guided prostate SBRT with focal boost: Results from the phase II PROBE trial

PSA and PSMA kinetics after PSMA-guided prostate SBRT with focal boost. Can the marker and uptake kinetics inform us of the good, the bad and the ugly? Read about it in the RedJournal @vedangmurthy @drmaneesh_singh @docpriyamvada @RadOncTMC


To evaluate PSA and PSMA kinetics following PSMA-PET and MR guided stereotactic body radiotherapy (SBRT) and short-term androgen deprivation therapy (ADT) with dominant intraprostatic lesion (DIL) boost in localised prostate cancer.

Exercise Protects Against Alzheimer’s, And Scientists May Finally Know Why

Among its numerous health benefits, physical activity reduces the risk of developing Alzheimer’s disease. A new study on mice now dives into the specific mechanisms and proteins that allow exercise to protect our brains.

Scientists had previously determined that physical activity increases a protein called glycosylphosphatidylinositol-specific phospholipase D1 in the blood of mice, and that this protein is associated with good brain health.

That protein – more succinctly referred to as GPLD1 – strengthens the barrier that guards the brain against all sorts of unwelcome visitors within our blood, protecting against inflammation and subsequent cognitive decline.

Abstract: Presenting a cutting-edge discovery on the mechanisms by which immune cells influence health and disease at the later stages of cerebral ischemic stroke

Here, Chuan Qin & team use complementary models in experimental ischemic stroke, showing early post-stroke stages in which microglia recruit B cells into ischemic lesions through MIF/CD74/CXCR4, while later stage post-stroke effects involve interferon signaling in B cells that drives neuroinflammation and brain injury:

The image shows B lymphocytes (Green) in mouse dura tissue colocalizing with CD31+ blood vessels (Red).


1Department of Neurology, Tongji Hospital, Tongji Medical College and State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases;

2Key Laboratory of Vascular Aging, Ministry of Education, Tongji Hospital of Tongji Medical College; and.

3Hubei Key Laboratory of Neural Injury and Functional Reconstruction, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Basal progenitors as drivers of neocortical expansion

Neocortical expansion driven by basal progenitors.

The emergence of indirect neurogenesis, driven by highly proliferative basal progenitors, contributed to the significant enlargement of the mammalian neocortex during brain evolution.

In recent years, several human-specific genes and enhancers have been described that differentially affect the biology of progenitor cells and potentially contribute to the increased neocortical complexity and disease-susceptibility of the human brain.

Emerging research is uncovering multiple pathways that disrupt basal progenitor biology, emphasizing these pathways’ involvement not only in classical neurogenesis-related disorders such as microcephaly but also in neurodevelopmental conditions traditionally linked to impairments in neuronal connectivity. sciencenewshighlights ScienceMission https://sciencemission.com/Basal-progenitors


The diversification and expansion of distinct progenitor cell subtypes during embryogenesis are essential to form the sophisticated brain structures present in vertebrates. In particular, the emergence of highly proliferative basal progenitors contributed to the evolutionary enlargement of the mammalian neocortex. Basal progenitors are at the center of indirect neurogenesis and can be divided into two main subtypes: the classical TBR2-positive intermediate progenitor cells and the outer radial glial cells, which are especially abundant in gyrencephalic species. While the function of some transcriptomic regulators is conserved across the mammalian clade, recent studies have identified human-specific genes and enhancers that uniquely affect progenitor biology, possibly driving the increased neocortical complexity and disease-susceptibility of the human brain.

/* */